Concepedia

Geertje J. D. van Mierlo

GJ

Statistics

Publications

13

Citations

1K

H-Index

12

Active since

2001

Affiliations

Leiden University Medical Center(Current)

Institute of Haematology and Blood Transfusion

The Netherlands Cancer Institute

Ophthalmology Associates (United States)

Geertje J. D. van Mierlo is an author at Leiden University Medical Center specializing in immunology, cancer immunology, and tumor immunology.

Publications per year

2001–2013

13

Publications

13

CD40 stimulation leads to effective therapy of CD40 <sup>−</sup> tumors through induction of strong systemic cytotoxic T lymphocyte immunity

Geertje J. D. van Mierlo, Annemieke Th. den Boer, Jan Paul Medema et al. · Proceedings of the National Academy of Sciences · 2002 · 224 citations · Full text

, , +17

Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8+ CTL to Cause Tumor Eradication

Geertje J. D. van Mierlo, Zita F. H. M. Boonman, Hélène Dumortier et al. · The Journal of Immunology · 2004 · 167 citations · Full text

, , +17

Apolipoprotein C-I Is Crucially Involved in Lipopolysaccharide-Induced Atherosclerosis Development in Apolipoprotein E–Knockout Mice

Marit Westerterp, Jimmy F.P. Berbée, Nuno Pires et al. · Circulation · 2007 · 139 citations

, , +17

Cutting Edge: TNFR-Shedding by CD4+CD25+ Regulatory T Cells Inhibits the Induction of Inflammatory Mediators

Geertje J. D. van Mierlo, Hans Ulrich Scherer, Marjolijn Hameetman et al. · The Journal of Immunology · 2008 · 111 citations · Full text

, , +17

In Vivo Triggering Through 4-1BB Enables Th-Independent Priming of CTL in the Presence of an Intact CD28 Costimulatory Pathway

Linda Diehl, Geertje J. D. van Mierlo, Annemieke Th. den Boer et al. · The Journal of Immunology · 2002 · 90 citations · Full text

, , +17

1–5 of 13